Document
PHCR USRealmHeader v2.1 No Optionals (2.16.840.1.113883.3.1937.99.61.20.10.15.1.1)
1. datatypelevel
  US Realm Date and Time (DTM.US.FIELDED) (2.16.840.1.113883.10.20.22.5.4)
2. datatypelevel
  US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
3. datatypelevel
  US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
4. datatypelevel
  US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
5. datatypelevel
  US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
6. datatypelevel
  US Realm Date and Time (DTM.US.FIELDED) (2.16.840.1.113883.10.20.22.5.4)
7. datatypelevel
  US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
8. datatypelevel
  US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
9. datatypelevel
  US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
10. datatypelevel
  US Realm Date and Time (DTM.US.FIELDED) (2.16.840.1.113883.10.20.22.5.4)
11. datatypelevel
  US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
12. datatypelevel
  US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
13. Header
  PHCR Documentation Of Template (2.16.840.1.113883.3.1937.99.61.20.10.16)
14. Header
  PHCR ComponentOf Template (2.16.840.1.113883.3.1937.99.61.20.10.14)
15. *
  PHCR Document Body (2.16.840.1.113883.3.1937.99.61.20.10.6)
  1. Section
    Encounters Section (entries required) (V3) (2.16.840.1.113883.3.1937.99.61.20.10.7)
    1. Entry
      Encounter Activity (V3) (2.16.840.1.113883.10.20.22.4.49)
      1. Entry
        Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      2. Entry
        Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      3. Entry
        Encounter Diagnosis (V3) (2.16.840.1.113883.10.20.22.4.80)
        
        Entry
        Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
        
        Entry
        Age Observation (2.16.840.1.113883.10.20.22.4.31)
        
        Entry
        Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
        
        Entry
        Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
        
        Entry
        Problem Status (2.16.840.1.113883.10.20.22.4.6)
  2. Section
    History of Present Illness Section (2.16.840.1.113883.3.1937.99.61.20.10.8)
  3. Section
    Medications Section (entries required) (V2) (2.16.840.1.113883.3.1937.99.61.20.10.9)
    1. Entry
      Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
      1. Entry
        Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
      2. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
        Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
      4. Entry
        Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
        Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
        Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
        
        Entry
        Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        
        Entry
        Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        
        Entry
        Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      7. Entry
        Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
        
        Entry
        Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        
        Entry
        Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        
        datatypelevel
        US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
        
        Entry
        Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
        
        Entry
        Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        
        Entry
        Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        
        Entry
        Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      8. Entry
        Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        
        Entry
        Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
        
        Entry
        Product Instance (2.16.840.1.113883.10.20.22.4.37)
        
        Entry
        Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        
        Entry
        Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        
        Entry
        Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        
        @
        Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        
        @
        Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        
        @
        Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        
        Entry
        Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      9. Entry
        Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
        
        datatypelevel
        US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
      10. Entry
        Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
      11. Entry
        Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
      12. Entry
        Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
  4. Section
    Problem Section (entries required) (V3) (2.16.840.1.113883.3.1937.99.61.20.10.10)
    1. Entry
      Problem Concern Act (V3) (2.16.840.1.113883.10.20.22.4.3)
      1. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
        Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
        
        Entry
        Age Observation (2.16.840.1.113883.10.20.22.4.31)
        
        Entry
        Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
        
        Entry
        Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
        
        Entry
        Problem Status (2.16.840.1.113883.10.20.22.4.6)
      3. Entry
        Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
    2. Entry
      Health Status Observation (V2) (2.16.840.1.113883.10.20.22.4.5)
  5. Section
    Reason for Visit Section (2.16.840.1.113883.3.1937.99.61.20.10.11)
  6. Section
    Results Section (entries required) (V3) (2.16.840.1.113883.3.1937.99.61.20.10.12)
    1. Entry
      Result Organizer (V3) (2.16.840.1.113883.10.20.22.4.1)
      1. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
        Result Observation (V3) (2.16.840.1.113883.10.20.22.4.2)
        
        notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
  7. Section
    Social History Section (V3) (2.16.840.1.113883.3.1937.99.61.20.10.13)
    1. Entry
      Social History Observation (V3) (2.16.840.1.113883.10.20.22.4.38)
      1. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
    2. Entry
      Pregnancy Observation (2.16.840.1.113883.10.20.15.3.8)
      1. Entry
        Estimated Date of Delivery (2.16.840.1.113883.10.20.15.3.1)
    3. Entry
      Smoking Status - Meaningful Use (V2) (2.16.840.1.113883.10.20.22.4.78)
      1. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
    4. Entry
      Tobacco Use (V2) (2.16.840.1.113883.10.20.22.4.85)
      1. notype
        Author Participation (2.16.840.1.113883.10.20.22.4.119)
    5. Entry
      Caregiver Characteristics (2.16.840.1.113883.10.20.22.4.72)
    6. Entry
      Cultural and Religious Observation (2.16.840.1.113883.10.20.22.4.111)
    7. Entry
      Characteristics of Home Environment (2.16.840.1.113883.10.20.22.4.109)